Cel-Sci
CVM
#10574
Rank
NZ$60.8 M
Marketcap
NZ$3.46
Share price
-0.51%
Change (1 day)
-80.08%
Change (1 year)

Cel-Sci (CVM) - P/B ratio

P/B ratio as of October 2026 : 3.10

According to Cel-Sci 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Cel-Sci - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-313.719.46%
2024-12-313.39-68.49%
2023-12-3110.7178.4%
2022-12-313.86-35.44%
2021-12-315.98-62.81%
2020-12-3116.1-65.99%
2019-12-3147.360.16%
2018-12-3129.5-671.6%
2017-12-31-5.16-280.47%
2016-12-312.86-79.02%
2015-12-3113.6203.68%
2014-12-314.49105.24%
2013-12-312.19-69.52%
2012-12-317.18-12.64%
2011-12-318.2211.11%
2010-12-317.3935.89%
2009-12-315.4457.29%
2008-12-313.46-17.36%
2007-12-314.19-116.23%
2006-12-31-25.8-289.3%
2005-12-3113.630.28%
2004-12-3110.5-52.21%
2003-12-3121.9102.53%
2002-12-3110.8

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.40 138.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
19.3 522.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
3.69 19.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
0.3464-88.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
6.25 101.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-4.81-255.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1.04-66.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
1.15-62.96%๐Ÿ‡บ๐Ÿ‡ธ USA